~~<i id='7332985993'><strike id='7332985993'><tt id='7332985993'><pre id='7332985993'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：knowledge 2025-09-03 03:26:38 - browse：75

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Republicans love RFK Jr. What's that tell us about health in 2024?

hotspot

leisure time

focus

leisure time

hotspot

3:34InthisApril30,2020,filephoto,WhiteHouseChiefofStaffMarkMeadowslistensasPresidentDonaldTrumpmeets

WSS

FDA panel issues narrow recommendation for Covid vaccine booster doses

How to use technology to prevent future drug shortages

American woman, child freed after being kidnapped in Haiti last month

Naloxone nonprofit donates 200,000 doses after FDA approval

California store owner shot dead in dispute over displaying Pride flag: Police

What to know about Virgin Galactic's 1st mission taking paying customers to space

leisure time

focus

hotspot

Medicare details structure of new drug price negotiation program

How the first Native Hawaiian psychiatrist helped diversify medicine

Cancer drug shortages should be causing more outrage

Friends ask where James Watson's attitudes about race came from

Virginia high school admissions case could be legal follow

The best solution to the drug shortages problem

Cancer drug shortages should be causing more outrage

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Apple is now the first public company to be valued at $3 trillion

Wegovy trial has doctors encouraged over new possibilities

leisure time

Emergent cuts jobs, executive role in business shake

Why failed clinical trials don’t always spell doom for a new drug

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

National associations that represent hospice owe an apology

CDC says it’s too soon to assess risk posed by Covid subvariant

Former Pear Therapeutics executives start new VC firm

focus

leisure time

leisure time

hotspot